# Zhejiang Huahai Pharmaceutical Co., Ltd. - Inspection Records

Source: https://www.keypedia.com/companies/zhejiang-huahai-pharmaceutical-co-ltd/77f8f66f-ca2e-4b91-b460-a4bd2041c866

> Inspection records and compliance data for Zhejiang Huahai Pharmaceutical Co., Ltd. in Zhejiang, 317024. Access full analysis and detailed observations.

---

## Details

- Name: Zhejiang Huahai Pharmaceutical Co., Ltd.
- FEI Number: 3003999190
- City: Zhejiang
- State: 317024
- Country Name: China
- Address Line 1: Taizhou
- Zip Code: China
- Facility Type: Finished Dosage Drug and API Manufacturer
- Business Operations: API MANUFACTURE, FDF MANUFACTURE

## Related Documents

- [483 - Zhejiang Huahai Pharmaceutical Co., Ltd. - Unknown Date](https://www.keypedia.com/records/483/zhejiang-huahai-pharmaceutical-co-ltd/73de650e-42cd-44dd-938a-9db63bd2aa36) — source: FDA, date: Invalid Date
- [483 - Zhejiang Huahai Pharmaceutical Co., Ltd. - 2025-04-16](https://www.keypedia.com/records/483/zhejiang-huahai-pharmaceutical-co-ltd/2ef1cc2c-83c1-438d-977d-2b5e750c3a15) — source: FDA, date: April 16, 2025
- [WARNING_LETTER - Zhejiang Huahai Pharmaceutical Co., Ltd. - 2025-01-24](https://www.keypedia.com/records/warning_letter/zhejiang-huahai-pharmaceutical-co-ltd/47330180-d7a6-4bdf-bf4a-82d60591d4e8) — source: FDA, date: January 24, 2025
- [FDA Inspection 1259818 - Zhejiang Huahai Pharmaceutical Co., Ltd. - 2025-01-24](https://www.keypedia.com/records/fda_inspections/zhejiang-huahai-pharmaceutical-co-ltd/92f6b7e9-21eb-46cb-8fa3-4bd171eb6e41) — source: FDA, date: January 24, 2025
- [FDA Inspection 1259818 - Zhejiang Huahai Pharmaceutical Co., Ltd. - 2025-01-24](https://www.keypedia.com/records/fda_inspections/zhejiang-huahai-pharmaceutical-co-ltd/6c8aed33-ef33-4a48-97c2-992934935373) — classification: Official Action Indicated (OAI), source: FDA, date: January 24, 2025
- [FDA Inspection 1149252 - Zhejiang Huahai Pharmaceutical Co., Ltd. - 2021-07-02](https://www.keypedia.com/records/fda_inspections/zhejiang-huahai-pharmaceutical-co-ltd/819ef1a0-aa32-4708-bc0f-a8399a97fb40) — classification: No Action Indicated (NAI), source: FDA, date: July 2, 2021
- [483 - Zhejiang Huahai Pharmaceutical Co., Ltd. - 2019-06-28](https://www.keypedia.com/records/483/zhejiang-huahai-pharmaceutical-co-ltd/90a0c6c6-2a30-43db-ab08-8293a7514d58) — source: FDA, date: June 28, 2019
- [483 - Zhejiang Huahai Pharmaceutical Co., Ltd. - 2019-05-31](https://www.keypedia.com/records/483/zhejiang-huahai-pharmaceutical-co-ltd/30c96b5f-fed4-4761-bd29-7764a4ff72bf) — source: FDA, date: May 31, 2019
- [FDA Inspection 1093250 - Zhejiang Huahai Pharmaceutical Co., Ltd. - 2019-05-31](https://www.keypedia.com/records/fda_inspections/zhejiang-huahai-pharmaceutical-co-ltd/2b5b7233-044f-42f2-ac3f-00e6696bfc49) — classification: Official Action Indicated (OAI), source: FDA, date: May 31, 2019
- [483 - Zhejiang Huahai Pharmaceutical Co., Ltd. - 2016-11-18](https://www.keypedia.com/records/483/zhejiang-huahai-pharmaceutical-co-ltd/f4b9c8ff-7a62-4903-afaa-573a00330b62) — source: FDA, date: November 18, 2016
- [FDA Inspection 993041 - Zhejiang Huahai Pharmaceutical Co., Ltd. - 2016-11-18](https://www.keypedia.com/records/fda_inspections/zhejiang-huahai-pharmaceutical-co-ltd/0b357083-d8c1-4b5b-9169-ab1f1c610575) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 18, 2016
- [FDA Inspection 921574 - Zhejiang Huahai Pharmaceutical Co., Ltd. - 2015-03-27](https://www.keypedia.com/records/fda_inspections/zhejiang-huahai-pharmaceutical-co-ltd/98610561-1547-4923-aaf6-de97c6883bb5) — classification: No Action Indicated (NAI), source: FDA, date: March 27, 2015
- [FDA Inspection 846044 - Zhejiang Huahai Pharmaceutical Co., Ltd. - 2013-08-09](https://www.keypedia.com/records/fda_inspections/zhejiang-huahai-pharmaceutical-co-ltd/d2281438-2496-4bdb-87bb-f6be38c566cb) — classification: No Action Indicated (NAI), source: FDA, date: August 9, 2013
- [FDA Inspection 709368 - Zhejiang Huahai Pharmaceutical Co., Ltd. - 2010-09-02](https://www.keypedia.com/records/fda_inspections/zhejiang-huahai-pharmaceutical-co-ltd/64d0341b-5b9b-4903-a44c-7ead22c99230) — classification: No Action Indicated (NAI), source: FDA, date: September 2, 2010

## Related Companies

- [Chemspec Chemicals Private Limited](https://www.keypedia.com/companies/chemspec-chemicals-private-limited/1146fa48-6575-4871-9f9f-d0123a964d22)
- [Novo Nordisk Pharmaceutical Industries LP](https://www.keypedia.com/companies/novo-nordisk-pharmaceutical-industries-lp/ae9a8861-e1ab-4878-a69f-e2f23284d455)
- [Medinatura New Mexico, inc.](https://www.keypedia.com/companies/medinatura-new-mexico-inc/9ac6fb13-d04a-47c0-984a-ed542030da80)
- [Novo Nordisk A/S](https://www.keypedia.com/companies/novo-nordisk-as/b48359f1-0bb7-4fff-80dd-688aab40951b)
- [TAILSTORM HEALTH INC](https://www.keypedia.com/companies/tailstorm-health-inc/dbf485de-61b3-4192-a026-6ed0b4008ff5)
- [Chromo Laboratories India Private Limited](https://www.keypedia.com/companies/chromo-laboratories-india-private-limited/2ad9e1f0-45cb-4dde-bab5-26579c1ca5e2)
- [Andelyn Biosciences, Inc.](https://www.keypedia.com/companies/andelyn-biosciences-inc/767017ae-d0c1-486f-b6ee-140770cf066e)
- [Max Chemical Inc](https://www.keypedia.com/companies/max-chemical-inc/622c32f0-42a1-4ae4-aeee-bd9125f0ed89)
- [Alto ICP, LLC](https://www.keypedia.com/companies/alto-icp-llc/bc6bac2f-8575-40c1-a90c-25f152eb71fd)
- [Les Importations Herbasante Inc.](https://www.keypedia.com/companies/les-importations-herbasante-inc/3d1eca38-4416-426d-a7ef-529d1e50ddf2)

## Related Officers

- [Research Specialist II](https://www.keypedia.com/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)
- [President](https://www.keypedia.com/people/peter-e-baker/c32eb848-de28-4725-80c9-ef8548d445bf)
- [investigator](https://www.keypedia.com/people/jonathan-w-chapman/5b5134c3-71f9-4212-9429-4554d91e8aa9)
- [Pharmaceuticals ](https://www.keypedia.com/people/zedong-dong/8ef8185c-523a-4b16-ab37-863746d71787)